Skip to main content

Main navigation

  • Rapid Reactions
  • Schizophrenia Foundations
  • Symptomatology
  • Patient Burden
  • Caregiver Perspectives
  • Psychopharmacology

Main navigation

  • Rapid Reactions
  • Schizophrenia Foundations
  • Symptomatology
  • Patient Burden
  • Caregiver Perspectives
  • Psychopharmacology

Can Peripherally Restricted Anticholinergics Like Trospium Reduce Risks?

September 17, 2025

HMP ยท Can Peripherally Restricted Anticholinergics Like Trospium Reduce Risks?

Greg Mattingly, MD examines safer alternatives and their limitations.

Related Content

Patient Case Studies: Successful Deprescription of Anticholinergics
Are There Guidelines for Deprescribing Anticholinergics?
Anticholinergic Misuse: Can These Medications Be Addictive?
How Do Emerging Muscarinic Agonists Like KarXT Affect Anticholinergic Use?
Assessing Anticholinergic Burden
How to Taper Anticholinergic Medications Safely
Why Should We Deprescribe Anticholinergics?
© 2026 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use Cookie Policy